AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 17.8 |
Market Cap | 3.10B |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | -0.22 |
PE Ratio (ttm) | -80.91 |
Forward PE | n/a |
Analyst | Buy |
Ask | 18.39 |
Volume | 323,570 |
Avg. Volume (20D) | 1,401,970 |
Open | 17.39 |
Previous Close | 17.28 |
Day's Range | 17.32 - 17.80 |
52-Week Range | 7.85 - 20.25 |
Beta | undefined |
About BTSG
BrightSpring Health Services, Inc. operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations. It serves patients through clinical providers and pharmacists. BrightSpring Health Services, Inc. was formerly known as Phoenix Paren...
Analyst Forecast
According to 13 analyst ratings, the average rating for BTSG stock is "Buy." The 12-month stock price forecast is $20, which is an increase of 12.36% from the latest price.
Next Earnings Release
Analysts project revenue of $2.95B, reflecting a 24.21% YoY growth and earnings per share of 0.2, making a -433.33% decrease YoY.
2 months ago · seekingalpha.com
BrightSpring Health Services, Inc. (BTSG) Q3 2024 Earnings Call TranscriptBrightSpring Health Services, Inc. (NASDAQ:BTSG ) Q3 2024 Earnings Conference Call November 1, 2024 8:30 AM ET Company Participants Jennifer Phipps - Chief Accounting Officer Jon Rousseau - President ...
3 months ago · seekingalpha.com
Global IPO Activity Picking Up But Continues To Lag Other Post-COVID YearsGlobal IPO activity is recovering but remains below recent years, with 326 IPOs in Q3 2024 totaling $23.32 billion, the lowest since Q1 2019. US IPO activity has increased steadily, with 36 IPOs in Q3...